{"id":"NCT00384033","sponsor":"Pfizer","briefTitle":"Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Duloxetine-Referenced, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (50mg, 100mg) of Desvenlafaxine Sustained-Release Tablets in Adult Outpatients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09","primaryCompletion":"2007-09","completion":"2007-09","firstPosted":"2006-10-04","resultsPosted":"2012-03-15","lastUpdate":"2012-03-15"},"enrollment":638,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Depressive Disorder, Major"],"interventions":[{"type":"DRUG","name":"Desvenlafaxine Succinate Sustained-Release (DVS SR)","otherNames":[]},{"type":"DRUG","name":"Desvenlafaxine Succinate Sustained-Release (DVS SR)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Duloxetine 60 mg/day","otherNames":[]}],"arms":[{"label":"Desvenlafaxine succinate sustained-release 50 mg","type":"EXPERIMENTAL"},{"label":"Desvenlafaxine succinate sustained-release 100 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Duloxetine 60mg","type":"OTHER"}],"summary":"The primary purpose of this study is to evaluate the efficacy and safety of two doses of DVS SR (50 and 100 mg/day) in the treatment of adults with Major Depressive Disorder.","primaryOutcome":{"measure":"Change From Baseline in HAM-D17 Total Score at Week 8 or Final On-therapy (FOT) Evaluation","timeFrame":"Baseline and Week 8 or FOT","effectByArm":[{"arm":"Placebo","deltaMin":-8.68,"sd":0.58},{"arm":"DVS SR 50 mg","deltaMin":-9.75,"sd":0.6},{"arm":"DVS SR 100 mg","deltaMin":-10.5,"sd":0.6},{"arm":"Duloxetine 60 mg","deltaMin":-10.3,"sd":0.6}],"pValues":[{"comp":"OG000 vs OG001","p":"0.198"},{"comp":"OG000 vs OG002","p":"0.028"},{"comp":"OG000 vs OG003","p":"0.047"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":["34183490","29140227","26709542","26644956","25758058","24571916","19698901"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3151A1-335&StudyName=Study%20Evaluating%20Desvenlafaxine%20Succinate%20Sustained%20Release%20%28DVS%20SR%29%20In%20The%20Treatment%20Of%20Major%20Depressive%20Disorder%20"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":161},"commonTop":["Withdrawal syndrome","Nausea","Headache","Dry mouth","Insomnia"]}}